化学品から医薬品への投資、新規事業立案について話せます

■背景
Takero Kurosawa currently serves as a Chief Operating Officer at DiveRadGel Co,.Ltd. is a pharmaceutical start-up, and our mission is to create groundbreaking cancer immunotherapies.
Prior to his role, he served as a Business Development at Asahi Kasei Corporation.
Before that, he served as a Management strategy consultant at Prored Partners. Expertise in building corporate strategy, business strategy, and Business and Financial Due Dilligence.
Prior to his role, he served as an Investment Analyst at Bluepass Capital Inc(10/2020-03/2021). Bluepass Capital is a Japanese Private Equity fund which is specializes for business successful investments. Responsible for sourcing part of M&A, Pre-investment due diligence.

■話せること
がん領域の医薬品開発、事業開発
化学品から医薬品への新規事業立案
新規事業立案に伴うJV組成、カーブアウト、スピンアウトベンチャーの設立と社内調整
化学品全般の事業投資、新規事業立案
成果報酬型の戦略コンサルティングサービス
M＆AにおけるセルサイドFA
ビジネスデューデリジェンス、ファイナンシャルデューデリジェンス
PEファンドが依頼者となるコンサルティングサービス
PEファンド設立業務、LP調達
PEファンドソーシングと初期DD